| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |